Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Cytokine-induced human IFN-gamma-secreting effector-memory Th cells in chronic autoimmune inflammation.
- A. Sattler, U. Wagner, +8 authors A. Thiel
- Biology, Medicine
- Blood
- 26 February 2009
T-helper (Th) cells activated by cytokines in the absence of T-cell receptor ligation are suspected to participate in inflammatory processes by production of interferon-gamma (IFN-gamma). Still, the… Expand
Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib.
- P. Bono, A. Krause, +5 authors H. Joensuu
- Medicine
- Blood
- 15 April 2004
Imatinib mesylate is a selective inhibitor of a few tyrosine kinases including KIT, and it is the first effective treatment for gastrointestinal stromal tumors (GISTs). We monitored the serum levels… Expand
Cytokines derived from alveolar macrophages induce fever after bronchoscopy and bronchoalveolar lavage
- A. Krause, B. Hohberg, F. Heine, M. John, G. R. Burmester, C. Witt
- Medicine
- 1 May 1997
As much as one-third of patients develop fever and flu-like symptoms after fiberoptic bronchoscopy (FOB) and bronchoalveolar lavage (BAL) for yet unknown reasons. The aim of the present study was to… Expand
Expression of the CD2 Activation Epitope T11‐3 (CD2R) on T Cells in Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Lyme Disease:…
- A. Potocnik, H. Menninger, +10 authors R. Kroczek
- Medicine, Biology
- Scandinavian journal of immunology
- 1 September 1991
CD2R is an activation‐associated epitope unmasked by a conformational change of the CD2 cell‐surface glycoprotein. In spite of elaborate studies on the role of CD2 and CD2R in adhesion and… Expand
Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: the Edinburgh experience.
- W. Miller, T. Anderson, S. White, D. Evans, A. Krause, J. Dixon
- Medicine
- Endocrine-related cancer
- 1 July 2005
Neoadjuvant endocrine treatment in which therapy is given while the primary tumour is still in the breast provides a highly useful model system by which to identify mechanisms associated with de novo… Expand
Pharmacokinetic/Pharmacodynamic Modelling of Receptor Internalization with CRTH2 Antagonists to Optimize Dose Selection
- A. Krause, J. Zisowsky, +4 authors J. Dingemanse
- Biology, Medicine
- Clinical Pharmacokinetics
- 1 July 2016
Background and ObjectiveThe chemoattractant receptor-homologous molecule expressed on T helper-2 cells (CRTH2) is a G-protein-coupled receptor for prostaglandin D2 (PGD2), a key mediator in… Expand
Modeling the Effect of the Selective S1P1 Receptor Modulator Ponesimod on Subsets of Blood Lymphocytes
- D. Lott, A. Krause, C. Seemayer, D. Strasser, J. Dingemanse, T. Lehr
- Medicine
- Pharmaceutical Research
- 1 March 2017
PurposeThis analysis aimed at describing the effect of the selective sphingosine-1-phosphate receptor 1 modulator ponesimod on lymphocyte subsets in peripheral blood. As the involvement of different… Expand
CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice
- A. P. Lange, L. Almeida, +5 authors E. Rego
- Biology, Medicine
- Brazilian journal of medical and biological…
- 27 May 2019
Although rare, CALM/AF10 is a chromosomal rearrangement found in immature T-cell acute lymphoblastic leukemia (T-ALL), acute myeloid leukemia, and mixed phenotype acute leukemia of T/myeloid lineages… Expand